ATLANTA (Reuters) - The Novartis diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and heart disease, according to a large study released on Sunday. The ...
Tenn. federal judge refuses to throw out lawsuits by patients claiming jaw damage A federal judge in Nashville has refused to dismiss 40 lawsuits against a Swedish-based pharmaceutical company accused of failing to warn patients that two of its drugs can cause ...
AMSTERDAM (Reuters) - The Dutch government wants to sell 21 million unused H1N1 flu vaccine doses back to their manufacturers after they proved unnecessary and no other country wanted to buy them, the Health Ministry said on Saturday. A spokeswoman for the ...
Nektar Therapeutics shares rise as Wall Street remains positive on product pipeline Shares of biotechnology company Nektar Therapeutics Inc. jumped Wednesday as analysts brushed off the report of a fourth-quarter loss and focused instead on the company's pipeline of products. The stock ...
<div><p>Pharmaceuticals company Novartis AG said Wednesday it is paying $125 million for an 85 percent stake in Chinese vaccine maker Zhejiang Tianyuan Bio-Pharmaceutical Co. Ltd.</p><p>Privately-held Tianyuan sells vaccines against diseases such as hemorrhagic fever with renal syndrome, or HFRS, caused by hantaviruses, ...
<div><p>Swiss pharmaceutical group Novartis said Tuesday that it would invest 1.0 billion dollars (680 million euros) in research and development in China to latch on to growing demand for health care.</p><p>The five-year investment will include an expansion of the company's Institute for ...
<div><p>Swiss pharmaceutical company Novartis AG said Thursday it has received regulatory approval in Germany for a new swine flu vaccine produced using cell cultures instead of egg-based methods.</p><p>Novartis described the approval as a "milestone" and said it is pursuing registration of the ...
<div><p>Swiss pharmaceuticals giant Roche and banking titan HSBC are among foreign firms being probed in South Korea for alleged involvement in illegal sales of swine flu treatment, officials said Friday.</p><p>The Korea Food and Drug Administration (FDA) said it raided the Seoul office ...
<div><p>ZURICH (Reuters) - A U.S. clinical study suggests that just half a dose of the Novartis AG H1N1 vaccine may be enough to generate a protective immune response, the Swiss drugmaker said on Tuesday.</p><p>Novartis said data from about 4,000 individuals suggested that ...
<div id="subtitle">Drug maker Novartis says lower dose of swine flu vaccine sufficient to guarantee immunity</div><div><p>Pharmaceutical maker Novartis AG said Tuesday a U.S. clinical study suggests that half a dose of its swine flu vaccine may be sufficient to protect people from the ...
